Treffer 1 - 2 von 2 für Suche 'Mardjuadi, F.I.', Suchdauer: 0,18s Treffer weiter einschränken
  1. 1
    994P Efficacy and safety of capmatinib plus spartalizumab in treatment-naïve patients with advanced NSCLC harboring MET exon 14 skipping mutation

    994P Efficacy and safety of capmatinib plus spartalizumab in treatment-naïve patients with advanced NSCLC harboring MET exon 14 skipping mutation von Wolf, J., Heist, R., Kim, T.M., Nishio, M., Dooms, C., Kanthala, R.R., Leo, E., Giorgetti, E., Wang, Y., Mardjuadi, F.I., Cortot, A.

    Veröffentlicht in Annals of oncology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Efficacy and safety of capmatinib plus spartalizumab in treatment-naive patients with advanced NSCLC harboring MET exon 14 skipping mutation

    Efficacy and safety of capmatinib plus spartalizumab in treatment-naive patients with advanced NSCLC harboring MET exon 14 skipping mutation von Wolf, J, Heist, R, Kim, T.M, Nishio, M, Dooms, C, Kanthala, R.R, Leo, E, Giorgetti, E, Wang, Y, Mardjuadi, F.I, Cortot, A


    Volltext
    Other

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: